BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31284000)

  • 1. Antiretroviral drug-induced endothelial dysfunction is improved by dual PPARα/γ stimulation in obesity.
    Kamau F; Strijdom H; Mwangi P; Blackhurst D; Imperial E; Salie R
    Vascul Pharmacol; 2019 Oct; 121():106577. PubMed ID: 31284000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist.
    Honda A; Kamata S; Satta C; Machida Y; Uchii K; Terasawa K; Nemoto A; Oyama T; Ishii I
    Biol Pharm Bull; 2021; 44(9):1210-1219. PubMed ID: 34471049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
    Joharapurkar A; Patel V; Kshirsagar S; Patel MS; Savsani H; Jain M
    Eur J Pharmacol; 2021 May; 899():174032. PubMed ID: 33753107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging.
    Zarzuelo MJ; López-Sepúlveda R; Sánchez M; Romero M; Gómez-Guzmán M; Ungvary Z; Pérez-Vizcaíno F; Jiménez R; Duarte J
    Biochem Pharmacol; 2013 May; 85(9):1288-96. PubMed ID: 23422569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis.
    Akbari R; Behdarvand T; Afarin R; Yaghooti H; Jalali MT; Mohammadtaghvaei N
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):53. PubMed ID: 34593018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Haemeoxygenase-1 Directly Improves Endothelial Function in Isolated Aortas from Obese Rats through the Ampk-Pi3k/Akt-Enos Pathway.
    Han F; Guo Y; Xu L; Hou N; Han F; Sun X
    Cell Physiol Biochem; 2015; 36(4):1480-90. PubMed ID: 26160485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway.
    Han F; Zhang S; Hou N; Wang D; Sun X
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1501-8. PubMed ID: 26371167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of vascular PPAR-γ contributes to endothelial dysfunction in high-fat diet-induced obese mice exposed to chronic intermittent hypoxia.
    Zhang Y; Zhang C; Li H; Hou J
    Biochem Biophys Res Commun; 2017 Oct; 492(2):243-248. PubMed ID: 28822761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alogliptin improves endothelial function by promoting autophagy in perivascular adipose tissue of obese mice through a GLP-1-dependent mechanism.
    Zhu B; Li Y; Mei W; He M; Ding Y; Meng B; Zhao H; Xiang G
    Vascul Pharmacol; 2019 Apr; 115():55-63. PubMed ID: 30447331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease.
    Kumar DP; Caffrey R; Marioneaux J; Santhekadur PK; Bhat M; Alonso C; Koduru SV; Philip B; Jain MR; Giri SR; Bedossa P; Sanyal AJ
    Sci Rep; 2020 Jun; 10(1):9330. PubMed ID: 32518275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial PPAR-γ provides vascular protection from IL-1β-induced oxidative stress.
    Mukohda M; Stump M; Ketsawatsomkron P; Hu C; Quelle FW; Sigmund CD
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H39-48. PubMed ID: 26566726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saroglitazar attenuates renal fibrosis induced by unilateral ureteral obstruction via inhibiting TGF-β/Smad signaling pathway.
    Makled MN; El-Kashef DH
    Life Sci; 2020 Jul; 253():117729. PubMed ID: 32348836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
    Jain MR; Giri SR; Bhoi B; Trivedi C; Rath A; Rathod R; Ranvir R; Kadam S; Patel H; Swain P; Roy SS; Das N; Karmakar E; Wahli W; Patel PR
    Liver Int; 2018 Jun; 38(6):1084-1094. PubMed ID: 29164820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary polyphenol morin rescues endothelial dysfunction in a diabetic mouse model by activating the Akt/eNOS pathway.
    Taguchi K; Hida M; Hasegawa M; Matsumoto T; Kobayashi T
    Mol Nutr Food Res; 2016 Mar; 60(3):580-8. PubMed ID: 26626705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saroglitazar, a novel dual PPAR-α/γ agonist, reverses high fat-low protein diet-induced metabolic and cognitive aberrations in C57BL/6J male mice.
    Dharavath RN; Arora S; Kondepudi KK; Bishnoi M; Chopra K
    Life Sci; 2021 Apr; 271():119191. PubMed ID: 33571514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition.
    Liu JT; Song E; Xu A; Berger T; Mak TW; Tse HF; Law IK; Huang B; Liang Y; Vanhoutte PM; Wang Y
    Br J Pharmacol; 2012 Jan; 165(2):520-31. PubMed ID: 21740414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling of Endothelial Nitric Oxide Synthase in Perivascular Adipose Tissue of Diet-Induced Obese Mice.
    Xia N; Horke S; Habermeier A; Closs EI; Reifenberg G; Gericke A; Mikhed Y; Münzel T; Daiber A; Förstermann U; Li H
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):78-85. PubMed ID: 26586660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saroglitazar reduces obesity and associated inflammatory consequences in murine adipose tissue.
    Kumar D; Goand UK; Gupta S; Shankar K; Varshney S; Rajan S; Srivastava A; Gupta A; Vishwakarma AL; Srivastava AK; Gaikwad AN
    Eur J Pharmacol; 2018 Mar; 822():32-42. PubMed ID: 29331565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence.
    Kaul U; Parmar D; Manjunath K; Shah M; Parmar K; Patil KP; Jaiswal A
    Cardiovasc Diabetol; 2019 Jun; 18(1):80. PubMed ID: 31208414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual identification of novel PPARα/γ dual agonists by scaffold hopping of saroglitazar.
    Jia WQ; Jing Z; Liu X; Feng XY; Liu YY; Wang SQ; Xu WR; Liu JW; Cheng XC
    J Biomol Struct Dyn; 2018 Oct; 36(13):3496-3512. PubMed ID: 29081262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.